West Chester-based professional training firm The Brooks Group has completed an internal management acquisition, signaling a strategic renewal while maintaining its core mission of providing specialized training and market research services to healthcare and pharmaceutical industries.
Ryan Evans, the company's new president, emphasized the acquisition represents a commitment to continued excellence and innovation. The transition comes as the company celebrates its 30th anniversary and marks the retirement of managing partner Dan Brooks, who has been with the organization since 1999.
The acquisition enables The Brooks Group to invest in advanced learning technologies, including AI-driven learning tools, customizable 3D simulations, and digital learning modules. These innovations aim to enhance the firm's ability to deliver cutting-edge professional development solutions across pharmaceutical, biotech, medical device, and healthcare sectors.
Evans noted the company will maintain its focus on improving client operating performance through customized training, strategic advisory services, and instructional design solutions. The new ownership structure positions the firm to expand its service offerings while leveraging its three decades of industry expertise.
The strategic move underscores The Brooks Group's commitment to remaining competitive by continuously adapting to evolving market needs and investing in next-generation learning technologies. By combining institutional knowledge with forward-looking innovation, the company aims to provide increasingly sophisticated professional development resources.
